The BNY Mellon Small Cap Value Fund underperformed its benchmark in Q4 2025 despite gains in technology. Read the full analysis for more details.
Two people who pleaded guilty to healthcare fraud after they used their Mesa clinic to obtain over $3 million in state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results